The content on this site is intended for healthcare professionals only
Dr Enrique Soto speaks to ecancer at the SIOG 2019 meeting in Geneva about the discussions from a breast cancer session looking at multidisciplinary views to the treatment of HER2 positive early breast cancer and triple negative early breast cancer in older adults.
He explains that it is important to increase the evidence base for treating older patients as older patients are often excluded form clinical trials meaning the information is often not there.
Dr Soto highlights that treatments should be tailored to the geriatric assessment and to the general needs of the patient.
This service has been kindly supported by unrestricted grants from Janssen Oncology and Sanofi Genzyme.
CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients
Grand Rounds: Improving quality of patient-centred care
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 25th - 31st, 2023
Advancing breast cancer treatment in Uganda by improving molecular testing
